Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilobradine Safety and Pharmacodynamics in Healthy Volunteers
NCT02264015Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2004
- Primary completion
- May 2004
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of cilobradine in angina pectoris and heart failure (HF), sponsored by Boehringer Ingelheim. Started Jan 2004; status: completed.
02
Drugs
cilobradine
03
Conditions
angina pectorisheart failure (HF)
Beyond the preview
Go deeper on NCT02264015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264015.